Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes

Vaccine

Volumn 23, Issue 3, 2004, Pages 343-352

  Vasconcelos, Nina Maria ^a   Siddique, Abu Bakar ^a   Ahlborg, Niklas ^a   Berzins, Klavs ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

B cell epitope; Multiple antigen peptide; T cell epitope

Indexed keywords

ASPARTYLPROLYLASPARAGINYLALANYLASPARAGINYLPROLYLASPARAGINYLVALINE; CIRCUMSPOROZOITE PROTEIN; EPITOPE; GAMMA INTERFERON; GLUTAMINYLTYROSYLISOLEUCYLLYSYLALANYLASPARAGINYLSERYLLYSYLPHENYLALANYL ISOLEUCYLGLYCYLISOLEUCYLTHREONYLGLUTAMYLLEUCINE; GLUTAMYLTYROSYLLEUCYLASPARAGINYLLYSYLISOLEUCYLGLUTAMINYLASPARAGINYLSERYL LEUCYLSERYLTHREONYLGLUTAMYLTRYPTOPHYLSERYLPROLYLCYSTEINYLSERYLVALYLTHREONINE; IMMUNOGLOBULIN G ANTIBODY; ISOLEUCYLGLUTAMYLLYSYLLYSYLISOLEUCYLALANYLLYSYLMETHIONYLGLUTAMYLLYSYL ALANYLSERYLSERYLVALYLPHENYLALANYLASPARAGINYLVALYLVALYLASPARAGINYLSERINE; LEUCYLVALYLSERYLGLUTAMYLGLUTAMYLISOLEUCYLVALYLTHREONYLGLUTAMYLGLUTAMYL GLYCYLSERYLVALYLALANYLGLUTAMINYLGLUTAMIC ACID; MALARIA VACCINE; OCTAPEPTIDE; PENTAPEPTIDE; PEPTIDE DERIVATIVE; TETANUS TOXIN; UNCLASSIFIED DRUG; VALYLTHREONYLGLUTAMYLGLUTAMYLISOLEUCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETICS; IMMUNE RESPONSE; IMMUNOGENICITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; CELLS, CULTURED; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMODIUM FALCIPARUM; SPECIES SPECIFICITY; T-LYMPHOCYTES; TETANUS TOXIN;

EID: 7744222635     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.003     Document Type: Article

References (49)

1. J.P. Tam Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system Proc. Natl. Acad. Sci. U.S.A. 85 15 1988 5409 5413
2. E.H. Nardin, G.A. Oliveira, J.M. Calvo-Calle, and R.S. Nussenzweig The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases Adv. Immunol. 60 1 1995 105 149
3. N. Ahlborg, E.H. Nardin, P. Perlmann, K. Berzins, and R. Andersson Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation Vaccine 16 1 1998 38 44
4. S.K. Chai, P. Clavijo, J.P. Tam, and F. Zavala Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes J. Immunol. 149 7 1992 2385 2390
5. J.P. Tam, P. Clavijo, Y.A. Lu, V. Nussenzweig, R. Nussenzweig, and F. Zavala Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria J. Exp. Med. 171 1 1990 299 306
6. E.H. Nardin, and R.S. Nussenzweig T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages Annu. Rev. Immunol. 11 1 1993 687 727
7. T.R. Burkot, Z.W. Da, H.M. Geysen, R.A. Wirtz, and A. Saul Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions Parasite Immunol. 13 2 1991 161 170
8. M.R. Hollingdale, E.H. Nardin, S. Tharavanij, A.L. Schwartz, and R.S. Nussenzweig Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies J. Immunol. 132 2 1984 909 913
9. D.Y. Munesinghe, P. Clavijo, M.C. Calle, R.S. Nussenzweig, and E. Nardin Immunogenicity of multiple antigen peptides (MAP) containing T- and B-cell epitopes of the repeat region of the P. falciparum circumsporozoite protein Eur. J. Immunol. 21 12 1991 3015 3020
10. J. Gysin, S. Gavoille, D. Mattei, A. Scherf, S. Bonnefoy, and O. Mercereau-Puijalon In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for sub-unit vaccines against the asexual blood stage of Plasmodium falciparum J. Immunol. Methods 159 1-2 1993 209 219
11. Berzins K, Perlmann P. Malaria vaccines: attacking infected erythrocytes. In: Hoffman SL, editor. Malaria Vaccine Development: A Multi-Immune Response Approach. Washington: American Society for Microbiology Press; 1996. p. 105-43.
12. N. Ahlborg, K. Berzins, and P. Perlmann Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2 Mol. Biochem. Parasitol. 46 1 1991 89 95
13. R. Udomsangpetch, J. Carlsson, B. Wahlin, G. Holmquist, L.S. Ozaki, and A. Scherf Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens J. Immunol. 142 10 1989 3620 3626
14. N. Ahlborg, R. Andersson, P. Perlmann, and K. Berzins Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332 Immunology 88 4 1996 630 635
15. N. Ahlborg, F. Sterky, D. Haddad, P. Perlmann, P.A. Nygren, and R. Andersson Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332 Mol. Immunol. 34 5 1997 379 389
16. P. Panina-Bordignon, A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia Universally immunogenic T-cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells Eur. J. Immunol. 19 12 1989 2237 2242
17. D. Valmori, A. Pessi, E. Bianchi, and G. Corradin Use of human universally antigenic tetanus toxin T-cell epitopes as carriers for human vaccination J. Immunol. 149 2 1992 717 721
18. F. Sinigaglia, M. Guttinger, J. Kilgus, D.M. Doran, H. Matile, and H. Etlinger A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules Nature 336 6201 1988 778 780
19. J.M. Calvo-Calle, J. Hammer, F. Sinigaglia, P. Clavijo, Z.R. Moya-Castro, and E.H. Nardin Binding of malaria T-cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T-cell epitope in the Plasmodium falciparum circumsporozoite protein J. Immunol. 159 3 1997 1362 1373
20. N. Ahlborg Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry J. Immunol. Methods 179 2 1995 269 275
21. C. Lambros, and J.P. Vanderberg Synchronization of Plasmodium falciparum erythrocytic stages in culture J. Parasitol. 65 3 1979 418 420
22. J.B. Jensen, and W. Trager Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method J. Parasitol. 63 5 1977 883 886
23. N. Ahlborg, J. Iqbal, M. Hansson, M. Uhlen, D. Mattei, and P. Perlmann Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence Parasite Immunol. 17 7 1995 341 352
24. K. Hinterberg, A. Scherf, J. Gysin, T. Toyoshima, M. Aikawa, and J.C. Mazie Plasmodium falciparum: the Pf332 antigen is secreted from the parasite by a brefeldin A-dependent pathway and is translocated to the erythrocyte membrane via the Maurer's clefts Exp. Parasitol. 79 3 1994 279 291
25. N. Ahlborg, I.T. Ling, A.A. Holder, and E.M. Riley Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1[19]) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19) Infect. Immunol. 68 4 2000 2102 2109
26. E.H. Nardin, J.M. Calvo-Calle, G.A. Oliveira, R.S. Nussenzweig, M. Schneider, and J.M. Tiercy A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T-cell epitopes elicits immune responses in volunteers of diverse HLA types J. Immunol. 166 1 2001 481 489
27. M.E. Ressing, W.J. van Driel, R.M. Brandt, G.G. Kenter, J.H. de Jong, and T. Bauknecht Detection of T-helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma J. Immunother. 23 2 2000 255 266
28. A. Kumar, R. Arora, P. Kaur, V.S. Chauhan, and P. Sharma "Universal" T-helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide J. Immunol. 148 5 1992 1499 1505
29. A. Moreno, P. Clavijo, R. Edelman, J. Davis, M. Sztein, and D. Herrington Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein Int. Immunol. 3 10 1991 997 1003
30. F.M. Ndungu, P.C. Bull, A. Ross, B.S. Lowe, E. Kabiru, and K. Marsh Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2 Parasite Immunol. 24 2 2002 77 82
31. O. Garraud, S. Mahanty, and R. Perraut Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design Trends Immunol. 24 1 2003 30 35
32. H. Bouharoun-Tayoun, C. Oeuvray, F. Lunel, and P. Druilhe Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages J. Exp. Med. 182 2 1995 409 418
33. A. Celada, A. Cruchaud, L.H. Perrin, S. Waki, S. Uehara, and K. Kanbe Assessment of immune phagocytosis of Plasmodium falciparum infected red blood cells by human monocytes and polymorphonuclear leukocytes A method for visualizing infected red blood cells ingested by phagocytes J. Immunol. Methods 63 2 1983 263 271
34. A.E. Tebo, P.G. Kremsner, and A.J. Luty Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro Exp. Parasitol. 98 1 2001 20 28
35. T. Yoneto, S. Waki, T. Takai, Y. Tagawa, Y. Iwakura, and J. Mizuguchi A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection J. Immunol. 166 10 2001 6236 6241
36. R.L. Hunter, M.R. Kidd, M.R. Olsen, P.S. Patterson, and A.A. Lal Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants J. Immunol. 154 4 1995 1762 1769
37. Z. Su, and M.M. Stevenson IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice J. Immunol. 168 3 2002 1348 1355
38. R.A. Cavinato, K.R. Bastos, L.R. Sardinha, R.M. Elias, J.M. Alvarez, and M.R. d'Imperio Lima Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments Parasite Immunol. 23 11 2001 587 597
39. B.D. Akanmori, S. Waki, and M. Suzuki Immunoglobulin G2a isotype may have a protective role in Plasmodium berghei NK65 infection in immunised mice Parasitol. Res. 80 8 1994 638 641
40. W.I. White, C.B. Evans, and D.W. Taylor Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii Infect. Immunol. 59 10 1991 3547 3554
41. S. Waki, S. Uehara, K. Kanbe, H. Nariuch, and M. Suzuki Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice Parasite Immunol. 17 10 1995 503 508
42. S.L. Constant, and K. Bottomly Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches Annu. Rev. Immunol. 15 1 1997 297 322
43. R.A. Gramzinski, C.L. Millan, N. Obaldia, S.L. Hoffman, and H.L. Davis Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration Mol. Med. 4 2 1998 109 118
44. E.A. McNeela, and K.H. Mills Manipulating the immune system: humoral versus cell-mediated immunity Adv. Drug Deliv. Rev. 51 1-3 2001 43 54
45. E.E. Comoy, A. Capron, and G. Thyphronitis In vivo induction of type 1 and 2 immune responses against protein antigens Int. Immunol. 9 4 1997 523 531
46. T.M. Daly, and C.A. Long Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection Infect. Immunol. 64 7 1996 2602 2608
47. L. Hadjipetrou-Kourounakis, and E. Moller Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo Scand. J. Immunol. 19 3 1984 219 225
48. T.P. Le, L.W. Church, G. Corradin, R.L. Hunter, Y. Charoenvit, and R. Wang Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants Vaccine 16 2-3 1998 305 312
49. M.B. Joshi, A.A. Gam, and R.A. Boykins Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates Infect. Immunol. 69 8 2001 4884 4890